-
Anhui starts the collection of cephalexin at the lowest price
Time of Update: 2021-07-27
On July 21, the Anhui Pharmaceutical Joint Procurement Office issued an announcement on the centralized procurement of cephalexin oral normal-release dosage forms .
The announcement clarified that the maximum effective declaration price for this renewal is 0.
Evaluation rules: The lowest price method after evaluation .
-
Press conference of the State Council Information Office: Carry out scientific tracing with a scientific attitude
Time of Update: 2021-07-27
Combining the research results of various aspects such as clinical epidemiology, animal and environmental testing, the joint expert group finally determined four possibilities for the emergence of the virus: the direct spillover of zoonotic diseases is "probable to more likely"; introduction through intermediate hosts It is "more likely to very likely"; it is "possible" to introduce it through the cold chain.
-
Betteni's independent director Yao Ronghui resigns and Li Zhiwei nominates the candidate
Time of Update: 2021-07-27
Yao Ronghui applied to resign as an independent director of the company, and at the same time He resigned from the audit committee, remuneration and appraisal committee, and nomination committee of the company's board of directors, and did not hold any other positions in the company .
-
All 13 volumes of "Chinese Medicinal Plants" published
Time of Update: 2021-07-27
Professor Liu Junyi, former dean of the School of Pharmacy of Peking University, pointed out in the preface that "Chinese Medicinal Flora" comprehensively, completely and systematically introduces the morphological classification, distribution, efficacy and application, chemical composition, pharmacological effects and use of medicinal plants in China.
-
China's generic drug development has changed dramatically in the past 6 years
Time of Update: 2021-07-27
Source: PharmaGo The huge market sales have become a driving force for companies to accelerate the completion of the consistency evaluation of generic drugs .
Source: PharmaGo Correspondingly, the number of products approved to pass the consistency evaluation of generic drugs is also increasing .
-
Puli Pharmaceutical Etibatide Injection Obtained Drug Registration Approval
Time of Update: 2021-07-27
On July 25, Puli Pharmaceuticals announced that it had recently received a drug registration approval for eptifibatide injection issued by the State Food and Drug Administration.
It was approved for listing in Europe in July 1999 and is now under the responsibility of GlaxoSmithKline.
-
National Medical Insurance Administration: Ensure that the cost of giving birth to three children is included in the payment scope of maternity insurance benefits
Time of Update: 2021-07-27
The National Medical Insurance Bureau requires that medical insurance departments in all regions should attach great importance to improving their political positions, actively adopt effective and efficient measures to ensure the implementation of the three-child reproductive treatment policy, and actively carry out positive publicity to enhance the sense of gain among the insured people .
-
Pfizer's new crown vaccine caused by delta strain drops to 39%
Time of Update: 2021-07-27
Previous data from the Israeli Ministry of Health showed that from May 2 to June 5, the effective rate of Pfizer's vaccine in preventing new crown infections in Israel was 94.
-
The new crown virus has spread in Europe in October 2019?
Time of Update: 2021-07-27
According to reports, scientists from the Milan Cancer Research Center-the National Cancer Institute (Istituto Nazionale Tumori) wrote in a new paper published on the 19th local time that the two laboratories collected a small amount of blood samples before the outbreak of the new crown epidemic.
-
Over 60 new drugs have been approved for clinical use, and the outbreak of bispecific antibodies is imminent?
Time of Update: 2021-07-27
Dozens of double antibodies entered the clinic Last year, WuXi Biologics published an article that counted the global selection of bispecific antibody target combinations (see the figure below) .
-
New research is expected to predict the risk of Alzheimer's disease in advance
Time of Update: 2021-07-27
Professor Han Ying, chairman of the Chinese Alzheimer’s Disease Preclinical Alliance and chief physician of the Department of Neurology at Xuanwu Hospital, pointed out that before MCI, there is a subjective cognitive decline (SCD)-and this is the breakthrough point for intervention , Which is the key to the "secondary prevention" of Alzheimer's disease .
-
Health Commission: 48 new confirmed cases on the 22nd, 12 in China
Time of Update: 2021-07-27
As of 24:00 on July 22, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 663 confirmed cases (including 17 severe cases), 87,163 cured and discharged cases, and 4,636 deaths.
-
The joint research report on the traceability of the new coronavirus can withstand the test of history
Time of Update: 2021-07-27
According to Zeng Yixin, deputy director of the National Health Commission, on March 30 this year, the World Health Organization officially released the global traceability study of the new crown virus convened by the World Health Organization: a joint research report on the Chinese part.
-
The second-stage traceability investigation plan should not violate common sense and science
Time of Update: 2021-07-27
" China-WHO Joint Research Expert on New Coronavirus Traceability Liang Wannian, the Chinese leader of the group, introduced at the press conference that the joint expert group went to Wuhan Virus Institute for a more detailed understanding, communicated with relevant researchers, including relevant management personnel, and inspected the site, especially for its standardization process and management.
-
Jiyu Pharmaceutical's SMO inhibitor approved in China
Time of Update: 2021-07-27
China National Medical Products Administration (NMPA) recently announced that a new class 5.
Public information shows that this is an SMO inhibitor that has been included in the priority review by the NMPA Drug Evaluation Center (CDE).
Screenshot source: NMPA official website
-
So far, no one at the Wuhan Institute of Virology has been infected with the new coronavirus
Time of Update: 2021-07-27
” In response to the issue of the second phase of the virus traceability plan released by the WHO on July 15 Zeng Yixin said, first of all, some rumors about the Wuhan Institute of Virology, "For example, three employees contracted the disease, for example, the Wuhan Institute of Virology carried out the new coronavirus function gain experiment, which is the Gain of function experiment.
-
Multinational pharmaceutical company's semi-annual report: Yang Sen's half-year sales of this drug are $5 billion and Roche's troika suffers
Time of Update: 2021-07-27
From the product point of view, Janssen Usnumab has sales of nearly US$5 billion, with strong growth and is expected to become a super blockbuster; Roche’s “troika” continues to be impacted by biosimilar drugs in H1, with the highest decline of Rituxan Monoclonal antibodies, sales of 1.
-
Health Commission: 35 new confirmed cases on the 23rd, 13 local cases
Time of Update: 2021-07-27
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 23 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 23 The l
-
Health Commission: On the 24th, 32 newly diagnosed cases and 5 local cases were confirmed
Time of Update: 2021-07-27
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 24 The latest situation of the novel coronavirus pneumonia as of 24:00 on July 24 The latest sit
-
Retests of blood samples show that the new coronavirus may have spread in Italy
Time of Update: 2021-07-27
In November last year, researchers from the National Cancer Institute of Milan published a paper in the country’s Journal of Oncology, stating that they tested blood samples from 959 volunteers who participated in a lung cancer screening test from September 2019 to March 2020.